Thai vaccine to enter third phase of trials 2021-11-18 Chulalongkorn University’s Centre of Excellence in Vaccine Research and Development expects to register its mRNA Covid-19 vaccine, known as ChulaCOV-19, mid-next year. Source : https://www.bangkokpost.com/thailand/general/2217743/thai-vaccine-to-enter-third-phase-of-trials Share FacebookTwitterPinterestWhatsApp Previous articleSPH stands ready to continue on its own if shareholders do not approve privatisation offersNext articleDutch weigh options to slow rising COVID-19 infections among children Latest Articles Why South Koreans Are Growing More Positive Toward Japan 2026-09-12 South Korea’s Housing Crisis Is Changing How Young People Plan Their Futures 2026-09-12 US derivatives regulator clears faster payouts for tipster awards under US$5 million 2026-09-12 S&P 500 ends higher as strong inflation data cements rate-hike bets 2026-09-11 DBS wants to be ‘Asian bank for Asians’ rather than global bank: CEO Tan Su Shan 2026-09-11 US core inflation up more than forecast, bolstering case for hike 2026-09-11